From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer
Clinicopathological parameters | SLC2A3 expression | p-value | |
---|---|---|---|
Low | High | ||
Age | |||
 < 60 | 8 | 13 | p = 0.533 |
 ≥ 60 | 8 | 15 |  |
Gender | |||
 Male | 12 | 18 | p = 0.350 |
 Female | 4 | 10 |  |
pStage | |||
 I | 5 | 2 | p = 0.049 |
 II–IV | 11 | 26 |  |
pT grade | |||
 T1, 2 | 7 | 4 | p = 0.037 |
 T3, 4 | 9 | 24 |  |
pN grade | |||
 N0 | 9 | 10 | p = 0.157 |
 N1–3 | 7 | 18 |  |
pM grade | |||
 M0 | 16 | 26 | p = 0.400 |
 M1 | 0 | 2 |  |
Total | 16 | 28 | Â |